Ligand Pharmaceuticals
LGND
LGND
345 hedge funds and large institutions have $3.88B invested in Ligand Pharmaceuticals in 2025 Q4 according to their latest regulatory filings, with 67 funds opening new positions, 111 increasing their positions, 115 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
7% more capital invested
Capital invested by funds: $3.63B → $3.88B (+$252M)
0.23% less ownership
Funds ownership: 104.62% → 104.39% (-0.23%)
3% less repeat investments, than reductions
Existing positions increased: 111 | Existing positions reduced: 115
Holders
345
Holding in Top 10
8
Calls
$6.71M
Puts
$1.76M
Top Buyers
| 1 | +$51.2M | |
| 2 | +$26.5M | |
| 3 | +$25.2M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
+$23.4M |
| 5 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
+$16.4M |
Top Sellers
| 1 | -$133M | |
| 2 | -$36M | |
| 3 | -$17.5M | |
| 4 |
SDJVC
St. Denis J. Villere & Co
New Orleans,
Louisiana
|
-$14.9M |
| 5 |
Aberdeen Group
Edinburgh,
United Kingdom
|
-$13.5M |
